The following is a summary of “Chronic graft-versus-host disease myelitis successfully treated with rituximab,” published in ...
MRI of dorsal spine was suggestive of myelitis at T7 vertebral level. She was initiated on injectable steroids and did show some initial signs of recovery. A day later, she developed an acute-onset ...
Guillain-Barre Syndrome (GBS) is a rare neurological disorder in which the body’s immune system mistakenly attacks the ...
GBS, a neurological condition triggered by an overactive immune system often after viral or bacterial infections, has been ...
Importance Chronic, intractable neuropathic pain is a common and debilitating consequence of neuromyelitis optica spectrum disorder (NMOSD) myelitis, with no satisfactory treatment; few studies have ...
14 天
WJAC Johnstown on MSNSomerset County 'cowboy' wins rodeo title just a year after devastating diagnosisFORT WORTH, Tx. — A seven-year-old boy from Somerset County won a 'mutton bustin' rodeo championship, just a year after receiving a devastating diagnosis. According to our NBC affiliate KXAS, Isaac ...
MUI FITNESS US (English) on MSN7 天
A Story of Triumph: The Heartwarming Documentary on Iñaki Basiloff That's Winning Hearts ...The Paralympic swimmer who became a world champion stars in a documentary that's sweeping global festivals. Discover the inspiring personal journey that's touching audiences everywhere.
Doctors at Poona Hospital report a rare Bickerstaff brainstem encephalitis case in a GBS patient, revealing multiple complications and unusual symptoms.
Laura McKenzie says she hopes to turn her personal challenges with accessibility into a passionate advocacy effort to raise awareness and push for a more inclusive community.
General side effects: tiredness, headache, muscle pain, chills, joint pain, fever, nausea, feeling unwell, swollen lymph ...
What you need to know ### BMJ Learning To obtain accredited continuous professional development points, subscribers to BMJ Learning can complete the full module at The module contains seven ...
Inc. today provided full-year Abecma® (idecabtagene vicleucel; ide-cel) sales results for 2024, in partnership with Bristol Myers Squibb (BMS). "We are pleased to see Abecma expansion in the third ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果